Selected research
Industry Growth & Trends
Global Skin Patch Industry Growth and Trends Forecast to 2032
Market perspective
The global Skin Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Skin Patch include GSK, Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Bayer and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Skin Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Skin Patch market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Skin Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Skin Patch.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Skin Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Skin Patch Market by Company
GSK
Teva Pharmaceutical Industries
Sanofi
Johnson & Johnson
Novartis
Mylan
Lingrui
Bayer
Teikoku Seiyaku
Purdue Pharma
Mundipharma International
Luye Pharma Group
Hisamitsu Pharmaceutical
Skin Patch Segment by Type
Buprenorphine
Fentanyl
Clonidine
Nicotine
Skin Patch Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Skin Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Buprenorphine
- Fentanyl
- Clonidine
- Nicotine
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- GSK
- Teva Pharmaceutical Industries
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- Lingrui
- Bayer
- Teikoku Seiyaku
- Purdue Pharma
- Mundipharma International
- Luye Pharma Group
- Hisamitsu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Skin Patch Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Skin Patch Sales Estimates and Forecasts (2021-2032)
- 1.3 Skin Patch Market by Type
- 1.3.1 Buprenorphine
- 1.3.2 Fentanyl
- 1.3.3 Clonidine
- 1.3.4 Nicotine
- 1.4 Global Skin Patch Market Size by Type
- 1.4.1 Global Skin Patch Market Size Overview by Type (2021-2032)
- 1.4.2 Global Skin Patch Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Skin Patch Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Skin Patch Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Skin Patch Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Skin Patch Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Skin Patch Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Skin Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Skin Patch Industry Trends
- 2.2 Skin Patch Industry Drivers
- 2.3 Skin Patch Industry Opportunities and Challenges
- 2.4 Skin Patch Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Skin Patch Revenue (2021-2026)
- 3.2 Global Top Players by Skin Patch Sales (2021-2026)
- 3.3 Global Top Players by Skin Patch Price (2021-2026)
- 3.4 Global Skin Patch Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Skin Patch Major Company Production Sites & Headquarters
- 3.6 Global Skin Patch Company, Product Type & Application
- 3.7 Global Skin Patch Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Skin Patch Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Skin Patch Players Market Share by Revenue in 2025
- 3.8.3 2025 Skin Patch Tier 1, Tier 2, and Tier 3
4 Skin Patch Regional Status and Outlook
- 4.1 Global Skin Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Skin Patch Historic Market Size by Region
- 4.2.1 Global Skin Patch Sales in Volume by Region (2021-2026)
- 4.2.2 Global Skin Patch Sales in Value by Region (2021-2026)
- 4.2.3 Global Skin Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Skin Patch Forecasted Market Size by Region
- 4.3.1 Global Skin Patch Sales in Volume by Region (2027-2032)
- 4.3.2 Global Skin Patch Sales in Value by Region (2027-2032)
- 4.3.3 Global Skin Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Skin Patch by Application
- 5.1 Skin Patch Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Skin Patch Market Size by Application
- 5.2.1 Global Skin Patch Market Size Overview by Application (2021-2032)
- 5.2.2 Global Skin Patch Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Skin Patch Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Skin Patch Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Skin Patch Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Skin Patch Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Skin Patch Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Skin Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 GSK Skin Patch Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Teva Pharmaceutical Industries
- 6.2.1 Teva Pharmaceutical Industries Company Information
- 6.2.2 Teva Pharmaceutical Industries Business Overview
- 6.2.3 Teva Pharmaceutical Industries Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Pharmaceutical Industries Skin Patch Product Portfolio
- 6.2.5 Teva Pharmaceutical Industries Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Skin Patch Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Company Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Johnson & Johnson Skin Patch Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Novartis Skin Patch Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Mylan
- 6.6.1 Mylan Company Information
- 6.6.2 Mylan Business Overview
- 6.6.3 Mylan Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mylan Skin Patch Product Portfolio
- 6.6.5 Mylan Recent Developments
- 6.7 Lingrui
- 6.7.1 Lingrui Company Information
- 6.7.2 Lingrui Business Overview
- 6.7.3 Lingrui Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Lingrui Skin Patch Product Portfolio
- 6.7.5 Lingrui Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bayer Skin Patch Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Teikoku Seiyaku
- 6.9.1 Teikoku Seiyaku Company Information
- 6.9.2 Teikoku Seiyaku Business Overview
- 6.9.3 Teikoku Seiyaku Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Teikoku Seiyaku Skin Patch Product Portfolio
- 6.9.5 Teikoku Seiyaku Recent Developments
- 6.10 Purdue Pharma
- 6.10.1 Purdue Pharma Company Information
- 6.10.2 Purdue Pharma Business Overview
- 6.10.3 Purdue Pharma Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Purdue Pharma Skin Patch Product Portfolio
- 6.10.5 Purdue Pharma Recent Developments
- 6.11 Mundipharma International
- 6.11.1 Mundipharma International Company Information
- 6.11.2 Mundipharma International Business Overview
- 6.11.3 Mundipharma International Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Mundipharma International Skin Patch Product Portfolio
- 6.11.5 Mundipharma International Recent Developments
- 6.12 Luye Pharma Group
- 6.12.1 Luye Pharma Group Company Information
- 6.12.2 Luye Pharma Group Business Overview
- 6.12.3 Luye Pharma Group Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Luye Pharma Group Skin Patch Product Portfolio
- 6.12.5 Luye Pharma Group Recent Developments
- 6.13 Hisamitsu Pharmaceutical
- 6.13.1 Hisamitsu Pharmaceutical Company Information
- 6.13.2 Hisamitsu Pharmaceutical Business Overview
- 6.13.3 Hisamitsu Pharmaceutical Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Hisamitsu Pharmaceutical Skin Patch Product Portfolio
- 6.13.5 Hisamitsu Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Skin Patch Sales by Country
- 7.1.1 North America Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Skin Patch Sales by Country (2021-2026)
- 7.1.3 North America Skin Patch Sales Forecast by Country (2027-2032)
- 7.2 North America Skin Patch Market Size by Country
- 7.2.1 North America Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Skin Patch Market Size by Country (2021-2026)
- 7.2.3 North America Skin Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Skin Patch Sales by Country
- 8.1.1 Europe Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Skin Patch Sales by Country (2021-2026)
- 8.1.3 Europe Skin Patch Sales Forecast by Country (2027-2032)
- 8.2 Europe Skin Patch Market Size by Country
- 8.2.1 Europe Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Skin Patch Market Size by Country (2021-2026)
- 8.2.3 Europe Skin Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Skin Patch Sales by Country
- 9.1.1 Asia-Pacific Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Skin Patch Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Skin Patch Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Skin Patch Market Size by Country
- 9.2.1 Asia-Pacific Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Skin Patch Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Skin Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Skin Patch Sales by Country
- 10.1.1 South America Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Skin Patch Sales by Country (2021-2026)
- 10.1.3 South America Skin Patch Sales Forecast by Country (2027-2032)
- 10.2 South America Skin Patch Market Size by Country
- 10.2.1 South America Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Skin Patch Market Size by Country (2021-2026)
- 10.2.3 South America Skin Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Skin Patch Sales by Country
- 11.1.1 Middle East and Africa Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Skin Patch Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Skin Patch Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Skin Patch Market Size by Country
- 11.2.1 Middle East and Africa Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Skin Patch Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Skin Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Skin Patch Value Chain Analysis
- 12.1.1 Skin Patch Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Skin Patch Production Mode & Process
- 12.2 Skin Patch Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Skin Patch Distributors
- 12.2.3 Skin Patch Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst